Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: A registry-based study.

Yet Hong KhorMax SchulteKerri A JohannsonVeronica MarcouxJolene H FisherDeborah AssayagHelene ManganasNasreen KhalilMartin R J KolbChristopher J Ryersonnull null

Published in: The European respiratory journal (2023)

Eligibility criteria of previous IPF RCTs have limited generalisability to clinical IPF populations, with FVC decline differing between eligible and ineligible populations.

Keyphrases

idiopathic pulmonary fibrosis
interstitial lung disease
genetic diversity
systemic sclerosis